[A patient with subcutaneous, lymph node and bone lesions for breast cancer: a progressive response to metronomic oral vinorelbine and capecitabine.]
The clinical case concerns a 75-year-old woman with operated breast cancer, hormone receptors positive, who is progressing to hormonal treatment at lymph nodes, skin and bone level. She is administered with metronomic chemotherapy based on capecitabine which is added, from the eighth cycle, oral vinorelbine. After 17 total cycles there is a progressive clinical response to the disease, particularly at the level of skin lesions that appear to be smoothed and reduced in volume. Treatment with oral vinorelbine and capecitabine in metronomic mode has also shown poor toxicity, easy handling and reduced hospital accesses.